These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 114319)

  • 1. [delta-9-Tetrahydrocannabinol (THC) inhibition of the membrane transport system for thymidine].
    Desoize B; Léger C; Nahas G
    C R Acad Hebd Seances Acad Sci D; 1978 Dec; 287(16):1441-4. PubMed ID: 114319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by THC of thymidine transport: a plasma membrane effect.
    Desoize B; Léger C; Jardillier JC; Nahas G
    Adv Biosci; 1978 Jul 22-23; 22-23():145-59. PubMed ID: 756825
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma membrane inhibition of macromolecular precursor transport by THC.
    Desoize B; Léger C; Nahas G
    Biochem Pharmacol; 1979 Apr; 28(7):1113-8. PubMed ID: 444268
    [No Abstract]   [Full Text] [Related]  

  • 4. delta-9-Tetrahydrocannabinol: effect on macromolecular synthesis in human and other mammalian cells.
    Blevins RD; Regan JD
    Arch Toxicol; 1976 Mar; 35(2):127-35. PubMed ID: 947311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic treatment with delta-9-tetrahydrocannabinol on uterine growth in the mouse.
    Paria BC; Wang XN; Dey SK
    Life Sci; 1994; 55(9):729-34. PubMed ID: 8065236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo inhibition of enterocyte metabolism by delta 9-tetrahydrocannabinol.
    Desoize B; Nahas GG; Latour C; Vistelle R
    Proc Soc Exp Biol Med; 1986 Apr; 181(4):512-6. PubMed ID: 3006078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic activity of cannabinoids.
    Munson AE; Harris LS; Friedman MA; Dewey WL; Carchman RA
    J Natl Cancer Inst; 1975 Sep; 55(3):597-602. PubMed ID: 1159836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of delta9-tetrahydrocannabinol in Lewis lung adenocarcinoma cells in tissue culture.
    White AC; Munson JA; Munson AE; Carchman RA
    J Natl Cancer Inst; 1976 Mar; 56(3):655-8. PubMed ID: 943561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential suppression of T-cell subpopulations by thc (delta-9-tetrahydrocannabinol).
    Pross SH; Klein TW; Newton CA; Smith J; Widen R; Friedman H
    Int J Immunopharmacol; 1990; 12(5):539-44. PubMed ID: 2170281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta-9-tetrahydrocannabinol treatment results in a suppression of interleukin-2-induced cellular activities in human and murine lymphocytes.
    Trisler K; Specter S
    Int J Immunopharmacol; 1994 Jul; 16(7):593-603. PubMed ID: 7523319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marijuana and immunity: tetrahydrocannabinol mediated inhibition of lymphocyte blastogenesis.
    Specter S; Lancz G; Hazelden J
    Int J Immunopharmacol; 1990; 12(3):261-7. PubMed ID: 2158486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues.
    Griffin G; Williams S; Aung MM; Razdan RK; Martin BR; Abood ME
    Br J Pharmacol; 2001 Jan; 132(2):525-35. PubMed ID: 11159703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of 3H-thymidine degradation in cell culture experiments with special reference to rheumatoid arthritis.
    Nykänen PJ; Raunio PV; Kankaanpää PU
    APMIS; 1988 Sep; 96(9):768-72. PubMed ID: 3166806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing effects of delta-9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulators.
    Pross SH; Nakano Y; Widen R; McHugh S; Newton CA; Klein TW; Friedman H
    Int J Immunopharmacol; 1992 Aug; 14(6):1019-27. PubMed ID: 1330945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of rhesus monkey lymphocytes to short-term administration of THC.
    Silverman AY; Darnell BJ; Montiel MM; Smith CG; Asch RH
    Life Sci; 1982 Jan; 30(1):107-15. PubMed ID: 6275230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol.
    Lu H; Kaplan BL; Ngaotepprutaram T; Kaminski NE
    J Leukoc Biol; 2009 Feb; 85(2):322-9. PubMed ID: 18988696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of delta 9-tetrahydrocannabinol and delta 9-11-tetrahydrocannabinol in rats and rhesus monkeys.
    Wiley JL; Barrett RL; Britt DT; Balster RL; Martin BR
    Neuropharmacology; 1993 Apr; 32(4):359-65. PubMed ID: 8388551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marijuana and immunity: tetrahydrocannabinol-mediated inhibition of growth and phagocytic activity of the murine macrophage cell line, P388D1.
    Tang JL; Lancz G; Specter S; Bullock H
    Int J Immunopharmacol; 1992 Feb; 14(2):253-62. PubMed ID: 1320592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of lymphocyte adenosine 3':5'-cyclic monophosphate (cAMP) by delta-9-tetrahydrocannabinol.
    Diaz S; Specter S; Coffey RG
    Int J Immunopharmacol; 1993 May; 15(4):523-32. PubMed ID: 8396073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cannabinoids on L1210 murine leukemia. 1. Inhibition of DNA synthesis.
    Tucker AN; Friedman MA
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):703-14. PubMed ID: 897352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.